(Q39604704)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

Efstathios N Stathopoulos

20 January 2020

6

object named as

Efstathios N Stathopoulos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Elisabeth de Araujo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Valérie Dessirier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Geneviève Laprée

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Laurence Valeyrie-Allanore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nicolas Ortonne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Martine Bagot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Maja Mockenhaupt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jean-Claude Roujeau

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Andreas Tsapis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Experimental Dermatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

107-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255088%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Toxic epidermal necrolysis: current evidence, practical management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Effector pathways during eczematous dermatitis: where inflammation meets cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Keratinocyte apoptosis in epidermal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Effects of isocamptothecin, a novel camptothecin analogue, on proliferation, apoptosis and telomerase activity in HaCaT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

T-lymphocyte-induced, Fas-mediated apoptosis is associated with early keratinocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X

Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01176.X